For further information: QUEST MANAGEMENT NV,
 Mr. René Avonts, Managing Director
 Tel: +32 (0)16 28 41 28
 Fax: +32 (0)16 28 41 29

 QUEST MANAGEMENT NV,
 Dr. William Brooks, Senior Investment Manager Life Sciences
 Tel: +32 (0)16 28 41 28
 Fax: +32 (0)16 28 41 29 

On Friday 18 February 2005 QUEST FOR GROWTH agreed to invest € 695,629 in IDEA AG, a dermatology company based in Munich, Germany as part of the Company’s Series D financing round. Other investors include 3i Group, MPM Capital and Life Sciences Partners. Quest may invest another € 1,305,371 into the company later this year. 

IDEA is a product company that develops therapeutics using self-optimising carriers for targeted and non-invasive delivery of drugs, including proteins.

The Company aims to establish itself as a specialty pharma company in dermatology, supported by milestones and royalties from its pain product development and commercialisation.

Each of IDEA’s product candidates is targeting a large pharmaceutical market with > 35m patients, using established, low risk drugs and innovative delivery technology platforms.

About IDEA AG   www.idea-ag.de   

IDEA AG is a product-oriented company that develops therapeutics using self-optimising carriers for targeted and non-invasive delivery of drugs, including proteins.

The basis of IDEA's proprietary technology are bio-compatible, highly deformable and self-regulating, water based agent carriers called Transfersomes®. The Company developed new transdermal product candidates of whom several are in the clinic; the current focus is on dermatological and pain therapeutics. IDEA is testing in the clinic Transfersome® formulations for the targeted transdermal delivery of steroidal or nonsteroidal anti-inflammatory drugs (NSAID); such drugs gain an improved safety profile and a high specificity through Transfersome® mediated delivery.

About QUEST FOR GROWTH    www.questforgrowth.com

The Privak “QUEST FOR GROWTH” is a Pan-European investment company that invests in European technology-based growth companies in a broad range of industrial sectors such as biotechnology, medical and health-care, semiconductors, telecommunications, software, electronics, information technology and new materials. QUEST FOR GROWTH invests in quoted and unquoted companies.

QUEST FOR GROWTH is Belgium’s first Privak and is an investment company traded on the continuous market of Euronext Brussels.

The Belgian Government created the legal and fiscal framework for the Privak as a tax transparent investment vehicle specially tailored to the needs of private equity.

The Privak “QUEST FOR GROWTH” is managed by Quest Management NV.

This announcement is not an offer to sell or a solicitation of an offer to buy any securities in the above companies in which QUEST FOR GROWTH has invested. This announcement appears solely as a matter of record.

The securities of the companies referred to in this document have not been registered with the United States Securities Act of 1933, and may not be offered or sold in the United States other than pursuant to an effective registration statement or an applicable exemption from registration.

This press release may contain forward-looking statements that involve risk and uncertainty. Although QUEST FOR GROWTH believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, no assurance can be given that such projections will be fulfilled. Any such forward-looking statement must be considered along with knowledge that actual events and results may vary materially from such predictions due to, among other things, political, economic or legal changes in the markets in which the companies in which QUEST FOR GROWTH invests do business or the stock markets in which these companies are listed. Readers are referred to the prospectus, which was issued at the time of the IPO that identifies the important risk factors proper to QUEST FOR GROWTH.

QUEST FOR GROWTH NV
Privak, established under Belgian Law
Lei 19, bus 3   B-3000 Leuven   -  Phone:  +32 (0)16 28 41 28  Fax: +32 (0)16 28 41 29

www.questforgrowth.com
quest@questforgrowth.com